Healthcare Finance News July 2, 2020
Jeff Lagasse

There was only a slight year-over-year dip in transactions recorded during the second quarter, suggesting a continued strategic rationale.

The COVID-19 pandemic is having a profound effect on hospital finances, exemplified by data showing that operating EBITDA margins fell a dramatic 174% in April, and remained down 9% year-over-year in May. So far, though, mergers and acquisition activity hasn’t taken as serious a blow. Transaction volumes are down from the norm, but only slightly, suggesting the public health crisis may be strengthening the rationale for future partnerships.

According to second-quarter data from Kaufman Hall, there were 14 transactions announced in the quarter. That’s a dip from the 29 transactions recorded in Q1, but year-over-year it’s not a significant change from...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Healthcare System, Mergers & Acquisitions / JV, Provider, Public Health / COVID, Survey / Study, Trends
Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Ten Things to Know About Consolidation in Health Care Provider Markets
Pacifica Adds 15 Communities in $180.5M Deal, as RHF Shifts Senior Living Strategy
PurposeCare Bucks Historic Home-Based Care M&A Inactivity Trend In Q1

Share This Article